Immunobiological effects of glucosamine in vitro

Scandinavian Journal of Immunology

Volumn 58, Issue 4, 2003, Pages 404-411

  Forchhammer, L ^a   Thorn, M ^b   Met, O ^a   Gad, M ^a   Weidner, M S ^b   Claesson, M H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Symbion Science Park   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUCOSAMINE; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MONOCLONAL ANTIBODY CD3; N ACETYLGLUCOSAMINE; OKT 4; TUMOR NECROSIS FACTOR ALPHA;

ALLOIMMUNITY; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BIOASSAY; CELL POLARITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; FEMALE; MIXED LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; FEMALE; GLUCOSAMINE; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES;

EID: 0141482053     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01313.x     Document Type: Article

References (28)

1. Lippiello L, Woodward J, Karpman R, Hammad TA. In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate. Clin Orthop 2000;381:229-40.
2. Reginster JY, Deroisy R, Rovati LC et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001;357:251-6.
3. McAlindon TE, LaValley MP, Felson DT. Efficacy of glucosamine and chondroitin for treatment of osteoarthritis. JAMA 2000;284:1241.
4. Ronca F, Palmieri L, Panicucci P, Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 1998;Suppl. A:14-21.
5. Salvatore S, Heuschkel R, Tomlin S et al. A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease. Aliment Pharmacol Ther 2000;14:1567-79.
6. Rao NV, Kennedy TP, Rao G, Ky N, Hoidal JR. Sulfated polysaccharides prevent human leukocyte elastase-induced acute lung injury and emphysema in hamsters. Am Rev Respir Dis 1990;142:407-12.
7. Ying QL, Kemme M, Saunders D, Simon SR. Glycosaminoglycans regulate elastase inhibition by oxidized secretory leukoprotease inhibitor. Am J Physiol 1997;272:533-41.
8. Matzner Y, Marx G, Drexler R, Eldor A. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis. Thromb Haemost 1984;52:134-7.
9. Kuschert GS, Coulin F, Power CA et al. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 1999;38:12959-68.
10. Shibata Y, Honda I, Justice JP, Van Scott MR, Nakamura RM, Myrvik QN. Th1 adjuvant N-acetyl-D-glucosamine polymer up-regulates Th1 immunity but down-regulates Th2 immunity against a mycobacterial protein (MPB-59) in interleukin-10-knockout and wild-type mice. Infect Immun 2001;69:6123-30.
11. Stevens L, Lowe J. Human Histology, 2nd edn. Mosby, London/Baltimore/New York 2000.
12. Gouze JN, Bianchi A, Becuwe P et al. Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway. FEBS Lett 2002;510:166-70.
13. Ma L, Rudert WA, Harnaha J et al. Immunosuppressive effects of glucosamine. J Biol Chem 2002;277:39343-9.
14. Komlos L, Ben-Efraim S, Lewis NJ, Hart J, Halbrecht I. Synergistic effect of N-acetyl-D-glucosamine (NAG) on mitogenic, antigenic and allogeneic stimulation of normal human lymphocytes. Int J Immunopharmacol 1984;6:593-9.
15. Grant EP, Rock KL. MHC class I-restricted presentation of exogenous antigen by thymic antigen-presenting cells in vitro and in vivo. J Immunol 1992;148:13-8.
16. Hugo P, Kappler JW, Godfrey DI, Marrack PC. A cell line that can induce thymocyte positive selection. Nature 1992;360:679-82.
17. Claesson MH, Hansen B, Ulrik J, Østergaard L, Skov S, Buus S. Antibodies directed against monomorphic and evolutionary conserved self epitopes can be generated in "knock-out" animals. Scand J Immunol 1994;40:257-64.
18. Schreurs MW, Eggert AA, de Boer AJ, Figdor CG, Adema GJ. Generation and functional characterization of mouse monocyte-derived dendritic cells. Eur J Immunol 1999;29:2835-41.
19. Thorpe R, Wadhwa M, Bird CR, Mire-Sluis AR. Detection and measurement of cytokines. Blood Rev 1992;6:133-48.
20. Qvirin Hansen N, Tscherning T, Claesson MH. T-Cell activation. IV. Evidence for a functional linkage between MHC class I, IL-2, and IL-4 receptor molecules. Cytokine 1991;3:35-41.
21. Burke MA, Morel BF, Oriss TB, Bray J, McCarthy SA, Morel PA. Modeling the proliferative response to IL-2 and IL-4. Cell Immunol 1997;178:42-52.
22. Foghsgaard L, Wissing D, Mauch D et al. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 2001;153:999-1110.
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. J Immunol Methods 1983;65:55-63.
24. Brams P, Claesson MH. T cell activation. I. Evidence for a functional linkage between class I MHC antigens and the TCRCD3 complex. Immunology 1989;66:348-53.
25. O'Neill HC, Parish CR. Monosaccharide inhibition of cytotoxic T-cell function: demonstration of clone-specific effects. Immunology 1988;64:181-4.
26. Yagita M, Nakajima M, Saksela E. Suppression of human natural killer cell activity by amino sugars. Cell Immunol 1989;122:83-95.
27. Wallach D, Arumugam TU, Boldin MP et al. How are the regulators regulated? The search for mechanisms that impose specificity on induction of cell death and NF-κB activation by members of the TNF/NGF receptor family. Arthritis Res 2002;4(Suppl. 3):189-96.
28. Komlos L, Ben-Efraim S, Lewis NJ, Hart J, Halbrecht K. Synergistic effect of N-acetyl-D-glucosamine (NAG) on mitogenic, antigenic and allogeneic stimulation of normal human lymphocytes. Int J Immunopharmacol 1984;6:593-9.